Enzymology and biosynthesis of the orsellinic acid derived medicinal meroterpenoids.
Journal
Current opinion in biotechnology
ISSN: 1879-0429
Titre abrégé: Curr Opin Biotechnol
Pays: England
ID NLM: 9100492
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
29
05
2020
revised:
02
11
2020
accepted:
30
11
2020
pubmed:
1
1
2021
medline:
3
7
2021
entrez:
31
12
2020
Statut:
ppublish
Résumé
The advent of synthetic biology has yielded fruitful studies on orsellinic acid-derived meroterpenoids, which reportedly possess important biological activities. Genomics and transcriptomics have significantly accelerated the discovery of the biosynthetic genes for orsellinic acid-derived fungal and plant meroterpenoids. Subsequently, a well-developed heterologous host provides a convenient platform to generate a supply of useful natural products. Furthermore, in vitro reconstitution and genome editing tools have been increasingly employed as efficient means to fully understand the enzyme reaction mechanisms. With the knowledge of the biosynthetic machinery, combinatorial and engineered biosyntheses have yielded novel molecules with improved bioactivities. These studies will lay the foundation for the production of meroterpenoids with novel medicinal properties.
Identifiants
pubmed: 33383296
pii: S0958-1669(20)30183-X
doi: 10.1016/j.copbio.2020.11.016
pii:
doi:
Substances chimiques
Biological Products
0
Resorcinols
0
orsellinic acid
11XLA0494B
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
52-59Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.